Related Experiment Video

Updated: Jul 8, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Rheumatic mitral valve surgery in the fifth decade: our experience

K S Rathore1, P Kumar, U Jadhav

  • 1Department of Cardiovascular and Thoracic Surgery, Lokmanya Tilak Medical College and Hospital, Sion, Mumbai, India. kaushalendra_rathore @hotmail.com

The Journal of Cardiovascular Surgery
|January 24, 2008
PubMed
Abstract

Insights

Older rheumatic mitral patients are surviving longer. This study found improved outcomes for patients over 50 undergoing valve replacement, though age and other factors remain key risks.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Valvular Heart Disease

Background:

  • Rheumatic heart disease increasingly affects patients into their fifth decade.
  • Improved life expectancy necessitates better management of rheumatic mitral valve disease in older adults.

Purpose of the Study:

  • To offer insights into reducing morbidity and mortality in rheumatic mitral patients aged 50 and above.
  • To evaluate outcomes of mechanical versus bioprosthetic valve replacement in this demographic.

Main Methods:

  • Retrospective analysis of 105 patients (≥50 years) undergoing valve replacement.
  • Comparison of mechanical (n=75) and bioprosthetic (n=30) valve groups.
  • Follow-up using echocardiography, clinical data, and X-rays.

Main Results:

  • Perioperative mortality was 4.76%, with a 3% long-term mortality rate.
  • Multivariate analysis identified age, repeat surgery, atrial fibrillation, tricuspid valve disease, and functional status as risk factors.
  • Freedom from reoperation at 6 years was 85%; actuarial survival at 6 years was 88.52%.

Conclusions:

  • Rheumatic valvular disease is increasingly seen in patients over 50.
  • Valve replacement shows marked improvement in this group, but age remains a significant risk factor.
  • Atrial fibrillation, repeat surgery, stroke, and tricuspid valve disease also impact outcomes.

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.